Cobalt-activated acylase activity in the serum of patients treated with lithium salts
Kiejna, A.; Leszek, J.; Janicka, B.
Polski Tygodnik Lekarski 38(30): 921-923
1983
ISSN/ISBN: 0032-3756 PMID: 6419211 Document Number: 213530
Document emailed within 1 workday
Related Documents
Modrzewska, R.; Rzeszowska, G.; Radomińska, I.; Patorska-Mach, E. 1980: Serum activity of cobalt-activated acylase in infectious mononucleosis Polski Tygodnik Lekarski 35(51): 2005-2007Modrzewska, R.; Rzeszowska, G.; Domańska, I.; Patorska-Mach, E. 1978: Serum activity of cobalt-activated acylase in Amanita phalloides poisoning Polski Tygodnik Lekarski 33(50): 1931-1933
Borowiak, K. 1995: Activity of choline esterases in blood cells and serum and cobalt activated acylase in toxic and non-toxic liver damage Annales Academiae Medicae Stetinensis 41: 145-154
Szewczuk, A.; Gladysz, A.; Szczeklik, A.; Wellman-Bednawska, M. 1977: Dics-test for cobalt-activated acylase activity and its use for early diagnosis of viral hepatitis Materia Medica Polona. Polish Journal of Medicine and Pharmacy 9(4): 282-285
Ragheb, M. 1987: Ibuprofen can increase serum lithium level in lithium-treated patients Journal of Clinical Psychiatry 48(4): 161-163
Savoldi, F.; Tartara, A.; Bo, P.; Zerbi, F. 1979: Long-term treatment with lithium salts and cerebral electric activity. Experimental research Bollettino della Societa Italiana di Biologia Sperimentale 55(7): 668-674
Habib, M.; Khalil, R.; le Pensec-Bertrand, D.; Ali-Cherif, A.; Bongrand, M.C.; Crevat, A. 1986: Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination? Revue Neurologique (Paris) 142(1): 61-64
Nora, R.M.; Hariprasad, M.K.; Beke, A.Z. 1981: Urinary osmolality in lithium and non-lithium treated psychiatric patients Journal of Clinical Psychiatry 42(6): 254
Szewczuk, A. 1971: The occurrence of Co ++ -activated acylase in animal tissues Archivum Immunologiae et Therapiae Experimentalis 19(3): 389-402
Curtis, J.R.; Goode, G.C.; Herrington, J.; Urdaneta, L.E. 1976: Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: a study of blood and tissue cobalt concentrations in normal subjects and patients with terminal and renal failure Clinical Nephrology 5(2): 61-65
Garry, P.J. 1971: Serum cholinesterase variants: examination of several differential inhibitors, salts, and buffers used to measure enzyme activity Clinical Chemistry 17(3): 183-191
Nagy, E.; Szegedi, G.; Tamási, P.; Sonkoly, I. 1978: Immune rosette inhibiting activity of serum from patients with chronic lupus erythematosus treated with chloroquin Dermatologische Monatschrift 164(6): 408-410
Zácková, P.; Krpálek, P.; Jaros, P.; Hájková, L. 1989: Plasma level of lithium in rats treated subchronically with lithium and tricyclic antidepressants Activitas Nervosa Superior 31(4): 277-279
Naccarato, R.; Rizzo, A.; Fagiolo, U.; Farini, R.; Erle, G. 1970: Behavior of circulating leucocytes ane various immunologic indices in cancer patients treated by cobalt therapy Giornale di Clinica Medica 51(9): 695-717
Reuter, H.D.; Schröter, G. 1980: Potassium, magnesium, copper, manganese and cobalt salts of aspartic acid on platelet factor 3 availability Arzneimittel-Forschung 30(12): 2106-2108
Yassa, R.; Ananth, J.; Mendis, T. 1980: Lithium salts in leukopenic disorders New York State Journal of Medicine 80(7 Part 1): 1076-1079
Pérez Martínez, J.M.; Portilla, J.; Bonora, V.; López Aldeguer, J. 1985: Poisoning caused by lithium salts Medicina Clinica 84(12): 500
Savoldi, F.; Nappi, G.; Bono, G. 1979: Lithium salts in the treatment of cluster headache Rivista di Neurologia 49(2): 128-139
Ghose, K. 1977: Lithium salts: therapeutic and unwanted effects British Journal of Hospital Medicine 18(6): 578-583
He, W.J.; Hu, Y.; Zhang, X.P.; Hong, M.; Guo, T.; Wei, W.N.; Song, S.J. 2008: Activated protein C ratio, plasma tissue factor activity and activated factor VIi in Chinese patients with coronary heart disease European Journal of Medical Research 13(2): 47-51